Capital World Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,938,589
| Closed | -$35.8M | – | 566 |
|
|
2024
Q2 | $35.8M | Sell |
13,938,589
-6,946
| -0% | -$17.9K | 0.01% | 413 |
|
|
2024
Q1 | $68.6M | Buy |
13,945,535
+2,006,459
| +17% | +$9.87M | 0.01% | 372 |
|
|
2023
Q4 | $105M | Sell |
11,939,076
-21,744
| -0.2% | -$191K | 0.02% | 337 |
|
|
2023
Q3 | $137M | Buy |
11,960,820
+2,385,946
| +25% | +$27.4M | 0.03% | 301 |
|
|
2023
Q2 | $242M | Sell |
9,574,874
-501,227
| -5% | -$12.7M | 0.05% | 252 |
|
|
2023
Q1 | $325M | Buy |
10,076,101
+595,945
| +6% | +$19.2M | 0.07% | 232 |
|
|
2022
Q4 | $175M | Buy |
9,480,156
+1,431,318
| +18% | +$26.4M | 0.04% | 291 |
|
|
2022
Q3 | $217M | Buy |
8,048,838
+3,458,838
| +75% | +$93.4M | 0.05% | 261 |
|
|
2022
Q2 | $63.4M | Buy |
4,590,000
+1,240,000
| +37% | +$17.1M | 0.01% | 371 |
|
|
2022
Q1 | $65.3M | Sell |
3,350,000
-362,000
| -10% | -$7.06M | 0.01% | 396 |
|
|
2021
Q4 | $60.6M | Buy |
3,712,000
+745,000
| +25% | +$12.2M | 0.01% | 419 |
|
|
2021
Q3 | $82.7M | Hold |
2,967,000
| – | – | 0.01% | 388 |
|
|
2021
Q2 | $87.9M | Buy |
2,967,000
+395,898
| +15% | +$11.7M | 0.01% | 394 |
|
|
2021
Q1 | $71.9M | Buy |
2,571,102
+441,102
| +21% | +$12.3M | 0.01% | 397 |
|
|
2020
Q4 | $60.4M | Hold |
2,130,000
| – | – | 0.01% | 396 |
|
|
2020
Q3 | $53.5M | Hold |
2,130,000
| – | – | 0.01% | 387 |
|
|
2020
Q2 | $52M | Hold |
2,130,000
| – | – | 0.01% | 363 |
|
|
2020
Q1 | $31.5M | Hold |
2,130,000
| – | – | 0.01% | 360 |
|
|
2019
Q4 | $34.6M | Buy |
2,130,000
+445,000
| +26% | +$7.22M | 0.01% | 376 |
|
|
2019
Q3 | $21.9M | Hold |
1,685,000
| – | – | 0.01% | 400 |
|
|
2019
Q2 | $21.9M | Hold |
1,685,000
| – | – | 0.01% | 431 |
|
|
2019
Q1 | $26.6M | Buy |
1,685,000
+460,000
| +38% | +$7.25M | 0.01% | 406 |
|
|
2018
Q4 | $24.7M | Hold |
1,225,000
| – | – | 0.01% | 415 |
|
|
2018
Q3 | $30.4M | Sell |
1,225,000
-210,000
| -15% | -$5.22M | 0.01% | 428 |
|
|
2018
Q2 | $39.4M | Buy |
+1,435,000
| New | +$39.4M | 0.01% | 389 |
|